Multi-strain probiotics ameliorate Alzheimer’s-like cognitive impairment and pathological changes through the AKT/GSK-3β pathway in senescence-accelerated mouse prone 8 mice

This publication has 40 references indexed in Scilit:

• Yuanzhi Powder inhibits tau pathology in SAMP8 mice: Mechanism research of a traditional Chinese formula against Alzheimer's disease
  Journal of Ethnopharmacology, 2023
• Exploring the microbiota-Alzheimer’s disease linkage using short-term antibiotic treatment followed by fecal microbiota transplantation
  Brain, Behavior, and Immunity, 2021
• Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
  Ageing Research Reviews, 2021
• Probiotics modulate the microbiota–gut–brain axis and improve memory deficits in aged SAMP8 mice
  Acta Pharmaceutica Sinica B, 2020
• Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease
  Behavioural Brain Research, 2019
• Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial
  Clinical Nutrition, 2019
• Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota
  Alzheimer's & Dementia, 2019
• Pigment Epithelium-Derived Factor Plays a Role in Alzheimer's Disease by Negatively Regulating Aβ42
  Neurotherapeutics, 2018
• Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus
  Neurochemical Research, 2016
• Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: A proteomics study
  Free Radical Biology and Medicine, 2013